{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:23:01Z","timestamp":1772234581789,"version":"3.50.1"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,4,1]]},"DOI":"10.1001\/jamaophthalmol.2020.0110","type":"journal-article","created":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T15:32:00Z","timestamp":1584027120000},"page":"418","source":"Crossref","is-referenced-by-count":13,"title":["An Iridociliochoroidal Myeloid Sarcoma Associated With Relapsed Acute Myeloid Leukemia With <i>FLT3-ITD<\/i> Mutation, Treated With Gilteritinib, an <i>FLT3<\/i> Inhibitor"],"prefix":"10.1001","volume":"138","author":[{"given":"Ryan S.","family":"Kim","sequence":"first","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Yaghy","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay R.","family":"Wilde","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol L.","family":"Shields","sequence":"additional","affiliation":[{"name":"Ocular Oncology Service, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"5","key":"elo200001r1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s10637-017-0470-z","article-title":"Gilteritinib, a FLT3\/AXL inhibitor, shows antileukemic activity in mouse models of FLT3 mutated acute myeloid leukemia.","volume":"35","author":"Mori","year":"2017","journal-title":"Invest New Drugs"},{"issue":"7","key":"elo200001r3","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/sj.eye.6701308","article-title":"Ophthalmic manifestations of acute leukaemias: the ophthalmologist\u2019s role.","volume":"18","author":"Sharma","year":"2004","journal-title":"Eye (Lond)"},{"issue":"2","key":"elo200001r4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41375-018-0357-9","article-title":"Targeting FLT3 mutations in AML: review of current knowledge and evidence.","volume":"33","author":"Daver","year":"2019","journal-title":"Leukemia"},{"issue":"8","key":"elo200001r5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1470-2045(17)30416-3","article-title":"Selective inhibition of FLT3 by gilteritinib in relapsed or refractory acute myeloid leukaemia: a multicentre, first-in-human, open-label, phase 1-2 study.","volume":"18","author":"Perl","year":"2017","journal-title":"Lancet Oncol"},{"key":"elo200001r6","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/01.HS9.0000561784.84381.11","article-title":"Gilteritinib significantly prolongs overall survival in patients with FLT3-mutated (FLT3MUT+) relapsed\/refractory (R\/R) acute myeloid leukemia (AML): results from the phase 3 ADMIRAL trial.","volume":"3","author":"Perl","year":"2019","journal-title":"HemaSphere"},{"key":"elo200001r2","volume-title":"Intraocular Tumors: An Atlas and Textbook","author":"Shields","year":"2016","edition":"3rd ed"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2762565\/jamaophthalmology_kim_2020_lo_200001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T15:05:25Z","timestamp":1586444725000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2762565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.0110","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,1]]}}}